Oscar Health OSCR
$24.73 −$1.44 (-5.50%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $24.95 +0.89%
Open$26.10
Prev close$26.17
Day range$24.55 – $26.78
Volume6.61M
Market cap$7.68B
P/E (TTM)11.0
Dividend yield–
Earnings
Average move on report day±11.0%last 16 reports
Closed higher10 of 1663% of the time
Best reaction+30.3%
Worst reaction-12.3%
Stock move on the day after each report
| Quarter | Report date | Timing | Implied move | Actual move | Versus implied |
|---|---|---|---|---|---|
| 2026/Q3 | 5 Nov 2026 | Pre Market | ±9.5% | -5.71% | Within range |
| 2026/Q2 | 6 Aug 2026 | Pre Market | ±11.0% | -11.86% | Bigger than priced |
| 2026/Q1 | 6 May 2026 | Pre Market | ±10.5% | +10.59% | Bigger than priced |
| 2025/Q4 | 10 Feb 2026 | Pre Market | ±12.5% | +1.74% | Within range |
| 2025/Q3 | 6 Nov 2025 | Pre Market | ±10.0% | -2.76% | Within range |
| 2025/Q2 | 6 Aug 2025 | Pre Market | ±11.6% | +3.76% | Within range |
| 2025/Q1 | 7 May 2025 | Pre Market | ±18.1% | +30.22% | Bigger than priced |
| 2024/Q4 | 4 Feb 2025 | After Market | ±20.7% | +3.08% | Within range |
| 2024/Q3 | 7 Nov 2024 | Pre Market | ±18.6% | -12.28% | Within range |
| 2024/Q2 | 7 Aug 2024 | Pre Market | ±15.9% | -3.08% | Within range |
| 2024/Q1 | 7 May 2024 | Pre Market | ±16.1% | +4.22% | Within range |
| 2023/Q4 | 7 Feb 2024 | After Market | ±16.4% | +24.38% | Bigger than priced |
| 2023/Q3 | 7 Nov 2023 | Pre Market | ±17.9% | +15.94% | Within range |
| 2023/Q2 | 8 Aug 2023 | After Market | ±16.1% | +12.06% | Within range |
| 2023/Q1 | 9 May 2023 | None | ±25.6% | -3.92% | Within range |
| 2022/Q4 | 9 Feb 2023 | After Market | ±36.3% | +30.26% | Within range |
"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$5.14B+72.1% YoY
Net profit$167.30M+221.7% YoY
Diluted EPS$0.49+192.5% YoY
Free cash flow-$1.21B-24.5% YoY
Operating cash flow-$1.20B
Revenue, last 8 quarters
Net profit, last 8 quarters
Profitability & balance sheet
Net margin4.9%
Return on equity52.7%
Return on assets10.9%
Liabilities / assets77.8%
Total debt$432.41M
Free cash flow / sales23.7%
No comments yet — be the first to weigh in on OSCR.
Sign in to join the discussion.